Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: DMT Strategy Study, MS and Genetic Mutations, MS Art Project, AI Helps Neuros Read MRIs

Alexa, News Relative Cancer Risk is Higher in MS Patients Who Switch Disease-modifying Treatments More Frequently, Study Finds

News Human Blood-brain Barrier in a Chip, Created in the Lab, May Help Design New Therapies, Study Shows

A Life in Letters -- A Column By Jamie Hughes, Columns How Does Your Garden Grow?

Columns, Fall Down, Get Up Again- a Column by John Connor What the Falck Is Going On?

Columns, The MS Wire - A Column by Ed Tobias Tony Awards ‘Cain’t Say No’ to Ali Stroker

News New AI Method Detects Brain Changes in Response to Treatment in RRMS Patients

News ‘Pregnancy Compensation Hypothesis’ May Explain Greater MS Risk for Women

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Is the Blood Brain Barrier?

Columns, Silver Linings - a Column by Jennifer Powell Move It or Lose It: Movement Is Crucial to Well-being with MS

News Elevated Blood Pressure May Predict Brain Bleeding in RRMS Patients Treated with Lemtrada, Study Suggests

News DELIVER-MS Trial Recruiting RRMS Patients to Help Improve Treatment Decision-making

News Biotech Startup Receives Funding to Pursue Cell-based Therapies for Neurological Disorders

News Muralist Lydia Emily Uses Art to Publicize Hardships of Life with MS

Columns, The MS Wire - A Column by Ed Tobias Making Invisible Patients Visible

News Aubagio Targets Highly Metabolic Auto-reactive T-Cells, Study Shows

News Study Identifies Possible Genetic Causes of MS

Columns, The MS Wire - A Column by Ed Tobias MS News That Caught My Eye Last Week: Ozanimod for RRMS, MS Monitoring App, Video Series

News Stem Cell Therapy Based on Exosomes May Treat MS, Study in Mice Suggests

Columns, Fall Down, Get Up Again- a Column by John Connor Thank You for Sharing

Columns, The MS Wire - A Column by Ed Tobias My MS Has Been No Sweat. Has Yours, Too?

News FDA and EMA to Review Ozanimod as Possible Oral Therapy for Relapsing MS

News Obesity, Altered Fat Levels May Worsen Severity of RRMS, Study Found

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Are MS Cooling Vests?

Columns, Silver Linings - a Column by Jennifer Powell Consortium for a Cure: Witnessing Hope

News Vitamin D’s Role in MS Likely More Result of Environment Than Genes, Study Suggests

News Roche, Sutter Health Testing Floodlight Mobile App That Monitors Patients’ MS

Columns, MSunderstood Millennial - a Column by Stephanie Towler I Am a Millennial with Multiple Sclerosis

News Blocking a Chemical Modification May Help Halt Inflammation in MS, Mouse Study Suggests

News 12-part Video Series, ‘Understanding Multiple Sclerosis,’ Available Online

News Vumerity’s Safety, Effectiveness Bolstered by New Data from EVOLVE-MS-1 Trial

News AxoSim Licenses Mini-Brain Technology, Which May Speed Therapy Discovery for Neurological Diseases

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Preventive MS Treatment, Clinical Trial Guidelines for Kids, Stress, and Gut Bacteria

News Mavenclad May Surpass Gilenya as DMT of Choice for Treatment of MS in Canada

News EMD Serono and ‘MS Inside Out’ Campaign Join Global Effort to Make MS More ‘Visible’

Columns, Fall Down, Get Up Again- a Column by John Connor A Wee Trip — But Not Like in the Past

Columns, The MS Wire - A Column by Ed Tobias Walmart Is Putting Quality of Employee MRIs Before Cost

News Abnormal Activation of Neutrophils a Potential Therapeutic Target in MS, Mouse Study Suggests

News Cyxone Nears First-in-human Trial for Investigational Preventive MS Treatment T20K

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: Why Are My Feet Burning?

Columns, Silver Linings - a Column by Jennifer Powell Chariots of Enlightenment: Overcoming My Fear of a Wheelchair

News MS International Federation Urges Participation in Visibility Campaign on World MS Day

News Canadians Wrap Up MS Awareness Month with ‘Acts of Greatness’ Campaign

News Celgene and MS Association of America Collaborating to Boost Knowledge on Brain Health in MS

News Corrona Expands MS Patient Registry to Include Genentech

Columns, The MS Wire - A Column by Ed Tobias To Handle MS, Sometimes We Need a Little Attitude

News IPMSSG Issues Guidelines on Participation of MS Youngsters in Clinical Trials

News Experts Gather for Consortium of Multiple Sclerosis Centers Annual Meeting

Columns, Fall Down, Get Up Again- a Column by John Connor Years of Laughter: It’s Been a Mammoth 40 Years

Columns, The MS Wire - A Column by Ed Tobias Why I Take My MS to the Gym

News First Patient Dosed in Phase 2B Trial Testing SAR442168 Therapeutic Candidate for RRMS

News MC10, AbbVie Plan Clinical Trials to Explore Using BioStamp nPoint Device for MS Patients

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Are Stem Cells?

Columns, Engaging Thoughts MS Study Looks at Minimizing and Preventing Falls for Wheelchair and Scooter Users

News Stress-induced Changes in Gut Bacteria May Increase Risk of Autoimmune Disorders, Mouse Study Suggests

News Early Safety Data from Phase 1 Study of Immunotherapy in Progressive MS Patients To Be Detailed at EAN

News Reactivation of Ancient Viruses May Be Involved in MS Inflammatory Response, Study Says

News Simvastatin, Common Statin, Treats SPMS in Ways Distinct from Cholesterol, Study Suggests

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson Staying Afloat in the Middle of the Storm

Columns, The MS Wire - A Column by Ed Tobias Humpty Dumpty and My MS

News Fibrinogen-containing Vesicles in Blood May Play Key Role in MS Relapses, Mouse Study Suggests

News EMD Serono Launches MS-LINK Research Network to Improve Patient Care

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: MS Biomarker, Best RRMS Early Treatment, Ocrevus Study, Out-of-Pocket Costs

News Study Testing Pear-006 Software Application for Treating Depression Symptoms

News #AANAM — Evobrutinib Continues to Show Potential for MS, 48-week Phase 2 Data Suggest

A Life in Letters -- A Column By Jamie Hughes, Columns As If You Needed Another Reason to Eat Cake

Columns, Fall Down, Get Up Again- a Column by John Connor Sunday Morning

News How Diet Helped Creator of Wahls Protocol in Personal MS Journey: A Nutritionist’s View

Columns, The MS Wire - A Column by Ed Tobias MS Is a Pain, and Doctors Should Know It

News Lyfebulb and Celgene Announce 2019 Innovation Challenge Finalists

News Out-of-Pocket Costs of MS Treatments in US Soared from 2004-16, Study Finds

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Is Dysarthria?

Columns, Silver Linings - a Column by Jennifer Powell Trading Teacups for Buckets: Keeping Dreams Alive with SPMS

News #AANAM — Gut Bacteria May Play Role in Pediatric MS, Studies Suggest

News #AANAM – Gilenya at 0.5 mg Superior to Copaxone at Lowering Relapses, Phase 3 Trial Shows

News #AANAM – Biogen Offers Update on Development Plans for MS Therapies

News #AANAM – 2 Trials Aim to Decide Best Early Way of Treating RRMS, Cleveland Clinic Doctor Says

News #AANAM — Use of Highly Effective Treatments for RRMS Increasing but Still Limited, Study Says

News #AANAM — Ocrevus Lowers Markers of Inflammation, Damage in Relapsing MS Patients, Phase 3 Trial Shows

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy, Infusions Vs. Pills

News Ocrevus Approved in UK as First NHS Treatment for PPMS

News #AANAM – Ocrevus Effective in RRMS Patients with Poor Responses to Other DMTs, Early Trial Data Suggest

News #AANAM – Aubagio at Higher Dose Shows Long-term Efficacy in Variety of Patients, Trial Data Show

Columns, Fall Down, Get Up Again- a Column by John Connor I Survived a Marathon Comedy Festival

News #AANAM – Interferon Beta Exposure Does Not Seem to Increase Risk of Pregnancy Complications, Study Suggests

Columns, The MS Wire - A Column by Ed Tobias Diets and Supplements: Do They Really Help Your MS?

News #AANAM – RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of Life

News #AANAM – Oral Ozanimod Better than Avonex in Lessening Brain Volume Loss in Relapsing MS, Trial Shows

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Is the ‘Barber Chair Phenomenon’?

Columns, Silver Linings - a Column by Jennifer Powell Perception Over Pain: Making a Mental Shift with SPMS

News #AANAM — Adamas Provides Update on Phase 3 INROADS Trial Testing ADS-5102 for MS

News #AANAM – Greater Exposure to Ocrevus Means Less Risk of Disability Progression in MS Patients, Study Contends

News #AANAM – Scoring Tool Helps Identify Patients with RRMS or Transitioning to SPMS, Study Reports

News #AANAM – Mayzent Improves Cognitive Processing Speed in SPMS Patients, Trial Results Show

News #AANAM — Quanterix Leads Research on Neurofilament Light Chain as Potential MS Biomarker

News #AANAM – Research Suggests Extended Interval Dosing of Tysabri Can Decrease Risk of PML

News #AANAM – Research Suggests Misconceptions About MS Risk in Pregnant Women

News #AANAM — Tysabri Lowers Serum Neurofilament Light Levels in SPMS Patients, Phase 3 Trial Finds

Columns, The MS Wire - A Column by Ed Tobias MS Meds Lead the Pack as Costs of Neuro Medications Rise

News #AANAM – Mayzent Lessens Inflammation at Brain Meninges, Prevents Migration of Lymphocytes to Reduce Demyelination, Mouse Study Suggests